| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiotensin converting enzyme inhibitors: Are they preferred first-line therapy?
|
Glasser, Stephen P.
|
|
2000
|
2 |
4 |
p. 392-397
|
artikel
|
| 2 |
Body mass determines clinical outcomes of antihypertensive treatment
|
Weber, Michael A.
|
|
2000
|
2 |
4 |
p. 352
|
artikel
|
| 3 |
Coronary heart disease prevention as the primary goal in contemporary trials in the treatment of hypertension
|
Sever, Peter S.
|
|
2000
|
2 |
4 |
p. 418-420
|
artikel
|
| 4 |
Evidence-based treatment of hypertension
|
Schoenberger, James A.
|
|
2000
|
2 |
4 |
p. 398
|
artikel
|
| 5 |
Hypertension and ischemic nephropathy
|
Alcázar, José
|
|
2000
|
2 |
4 |
p. 343-344
|
artikel
|
| 6 |
Importance of various methods of blood pressure measurement in clinical trials
|
Palatini, Paolo
|
|
2000
|
2 |
4 |
p. 362-369
|
artikel
|
| 7 |
Literature alert
|
|
|
2000
|
2 |
4 |
p. 347-351
|
artikel
|
| 8 |
Mechanism of differential effects of antihypertensive agents on serum lipids
|
Brook, Robert D.
|
|
2000
|
2 |
4 |
p. 370-377
|
artikel
|
| 9 |
Prehypertension: A possible target for antihypertensive medication
|
Nesbitt, Shawna D.
|
|
2000
|
2 |
4 |
p. 356-361
|
artikel
|
| 10 |
The promise of selective aldosterone receptor antagonists for the treatment of hypertension and congestive heart failure
|
Hameedi, Asim
|
|
2000
|
2 |
4 |
p. 378-383
|
artikel
|
| 11 |
Therapeutic trials comparing angiotensin converting enzyme inhibitors and Angiotensin II receptor blockers
|
Elliott, William J.
|
|
2000
|
2 |
4 |
p. 402-411
|
artikel
|
| 12 |
Treatment of white coat hypertension
|
Chrysant, Steven G.
|
|
2000
|
2 |
4 |
p. 412-417
|
artikel
|
| 13 |
Vasopeptidase inhibition: A new direction in cardiovascular treatment
|
Asher, Jordan R.
|
|
2000
|
2 |
4 |
p. 384-391
|
artikel
|
| 14 |
Web alert
|
|
|
2000
|
2 |
4 |
p. 345-346
|
artikel
|
Tijdschrift beschrijving